Warning: session_start(): open(/tmp/sess_e867182c4b01ea54fd7bc0b5f161ee8f, O_RDWR) failed: Disk quota exceeded (122) in /home/diasporacomm2014/public_html/wp-content/plugins/ajax-bootmodal-login/alimir-bootmodal-login.php on line 11

Warning: session_start(): Cannot send session cookie - headers already sent by (output started at /home/diasporacomm2014/public_html/wp-content/plugins/ajax-bootmodal-login/alimir-bootmodal-login.php:11) in /home/diasporacomm2014/public_html/wp-content/plugins/ajax-bootmodal-login/alimir-bootmodal-login.php on line 11

Warning: session_start(): Cannot send session cache limiter - headers already sent (output started at /home/diasporacomm2014/public_html/wp-content/plugins/ajax-bootmodal-login/alimir-bootmodal-login.php:11) in /home/diasporacomm2014/public_html/wp-content/plugins/ajax-bootmodal-login/alimir-bootmodal-login.php on line 11
WHO fears Ebola vaccine may not see light of day as epidemic nears end | Diaspora Community. Welcome Back Home!

WHO fears Ebola vaccine may not see light of day as epidemic nears end

May 15, 2015

Last weekend, a significant milestone when Liberia was declared Ebola free, having gone 42 days without a new case of the virus. While this is definitely a positive development, there are concerns that further vaccine trials will fail to provide enough insight on the degree of protection offered against the virus.

This twist in the Ebola narrative was recently disclosed by the World Health Organization (WHO) after officially declaring Liberia free of the disease. The epidemic, which lasted for about a year killed more than 4,700 people in Liberia. Neighbouring countries Guinea and Sierra Leone reported 10 and 2 cases respectively last week, confirming a gradual tilt towards the zero case target.

Presently, two experimental Ebola vaccines are being tested on volunteers but may not yield sufficient data on efficacy as the number of cases continue to shrink. According to Dr. Marie-Paule Kieny, WHO Assistant Director-General for Health Systems and Innovation, these vaccines were developed by GlaxoSmithKline and jointly by Merck and NewLink Genetics. Two other drugs including the already known Zmapp will also be tested, going forward. “The best news is we are going to zero cases, there is absolutely no doubt about that. It is not clear whether it will be possible to have even a hint of efficacy from these two vaccines. To have efficacy we must see if people are actually protected, as the number of cases is going down it is not clear whether there will be a strong robust answer to this question at the end of epidemic.”

The health body continues to hold meetings with experts on developing a plan to expedite the production of vaccines and drugs that can be used during any future epidemic. A deal on research and development could potentially be reached by the end of the year.

Source: Ventures Africa

(0 votes) 0/5
Article Tags:
Article Categories:
Health

Leave a Comment

Please wait...

Subscribe to our newsletter

Want to be notified when our article is published? Enter your email address and name below to be the first to know.

Warning: Unknown: open(/tmp/sess_e867182c4b01ea54fd7bc0b5f161ee8f, O_RDWR) failed: Disk quota exceeded (122) in Unknown on line 0

Warning: Unknown: Failed to write session data (files). Please verify that the current setting of session.save_path is correct (/tmp) in Unknown on line 0